Literature DB >> 6896326

Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination.

G R Crabtree, J A Kant.   

Abstract

Cell-free translation and hybridization to cloned cDNA probes were used to study variations in fibrinogen mRNA levels in the livers of rats injected with Malayan pit viper venom and glucocorticoids. Animals defibrinated with Malayan pit viper venom showed a rapid and substantial increase in the relative abundance of hepatic mRNAs for the A alpha, B beta, and gamma chains of fibrinogen. The onset, rate, and maximal extent of message accumulation were virtually identical for each of the three fibrinogen polypeptide chains. This response was detectable 1-2 h after injection of venom and, by 12-16 h, fibrinogen species made up approximately 10% of the polyadenylated RNA compared to less than 1% in noninjected animals. Physiologic levels of glucocorticoids appeared to be necessary for maximal levels of message; adrenalectomized animals had a median 4.8-fold increase in fibrinogen mRNA species after defibrination compared with a 12.5-fold increase in normal animals. Although it is uncertain whether the changes in mRNA levels are a function of increased transcription or message stabilization, the similar kinetics of accumulation suggest that a common mechanism is responsible for coordinating the levels of each fibrinogen mRNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896326

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Sp1, a CAAT-binding factor, and the adenovirus major late promoter transcription factor interact with functional regions of the gamma-fibrinogen promoter.

Authors:  J G Morgan; G Courtois; G Fourel; L A Chodosh; L Campbell; E Evans; G R Crabtree
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

2.  Localization of DNA sequences involved in dexamethasone-dependent expression of the rat alpha 1-acid glycoprotein gene.

Authors:  H Baumann; L E Maquat
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

3.  Characterization of the 5'-flanking region for the human fibrinogen beta gene.

Authors:  P Huber; J Dalmon; G Courtois; M Laurent; Z Assouline; G Marguerie
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

Review 4.  Hepatic acute phase reaction in vivo and in vitro.

Authors:  H Baumann
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

5.  Biosynthesis, assembly and secretion of fibrinogen in cultured rat hepatocytes.

Authors:  S Hirose; K Oda; Y Ikehara
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

6.  Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion.

Authors:  J A Kant; A J Fornace; D Saxe; M I Simon; O W McBride; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

7.  The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2.

Authors:  I Henry; G Uzan; D Weil; H Nicolas; J C Kaplan; C Marguerie; A Kahn; C Junien
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

8.  Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5' flanking regions.

Authors:  D M Fowlkes; N T Mullis; C M Comeau; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Regulation of major acute-phase plasma proteins by hepatocyte-stimulating factors of human squamous carcinoma cells.

Authors:  H Baumann; R E Hill; D N Sauder; G P Jahreis
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

10.  The influence of glucocorticoid on the fibrinogen messenger RNA content of rat liver in vivo and in hepatocyte suspension culture.

Authors:  H M Princen; H J Moshage; H J de Haard; P J van Gemert; S H Yap
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.